Literature DB >> 9922348

Marked variation in the cardiomyopathy associated with Friedreich's ataxia.

D P Dutka1, J E Donnelly, P Nihoyannopoulos, C M Oakley, D J Nunez.   

Abstract

OBJECTIVE: To document the cardiac phenotype associated with Friedreich's ataxia, a recessively inherited disorder characterised by spinocerebellar degeneration.
SETTING: Individuals with Friedreich's ataxia who accepted the invitation to participate in the study. HYPOTHESIS: The cardiomyopathy associated with Friedreich's ataxia may offer a human model for the study of factors modulating cardiac hypertrophy.
METHODS: 55 patients (mean (SD) age 30 (9) years) with a clinical diagnosis of Friedreich's ataxia were studied by clinical examination, electrocardiography, cross sectional and Doppler echocardiography, and analysis of the GAA repeat in the first intron of the frataxin gene.
RESULTS: A wide variety of cardiac morphology was documented. Subjects with normal frataxin alleles had no evidence of cardiomyopathy. In homozygous subjects, a relation was found between the thickness of the interventricular septum (r = 0.53, p < 0.005), left ventricular mass (r = 0.48, p < 0.01), and the number of GAA repeats on the smaller allele of the frataxin gene. No relation was shown between the presence of electrocardiographic abnormalities (mainly repolarisation changes) and either the pattern of ventricular hypertrophy (if present) and degree of neurological disability or the length of time since diagnosis. No tendency to ventricular thinning or dilatation with age was found. Although ventricular systolic function appeared impaired in some cases, Doppler studies of ventricular filling were within the normal range for age.
CONCLUSIONS: The cardiomyopathy associated with Friedreich's ataxia shows a variable phenotype which is not concordant with the presence of ECG abnormalities or the neurological features of the condition. As the genetic basis for Friedreich's ataxia has been established, further studies will help to clarify the molecular mechanisms of the cardiac hypertrophy.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9922348      PMCID: PMC1728941          DOI: 10.1136/hrt.81.2.141

Source DB:  PubMed          Journal:  Heart        ISSN: 1355-6037            Impact factor:   5.994


  31 in total

1.  Cardiomyopathy in Friedreich's ataxia: a Doppler-echocardiographic study.

Authors:  D Morvan; M Komajda; L D Doan; A Brice; R Isnard; A Seck; P Lechat; Y Agid; Y Grosgogeat
Journal:  Eur Heart J       Date:  1992-10       Impact factor: 29.983

2.  Noninvasive assessment of systolic and diastolic function in 50 patients with Friedreich's ataxia.

Authors:  A Giunta; S Maione; R Biagini; A Filla; G De Michele; G Campanella
Journal:  Cardiology       Date:  1988       Impact factor: 1.869

3.  The heart in Friedreich's ataxia.

Authors:  R Hewer
Journal:  Br Heart J       Date:  1969-01

4.  Hypertrophic cardiomyopathy: the heart disease of Friedreich's ataxia.

Authors:  E R Smith; V E Sangalang; L P Heffernan; J P Welch; C S Flemington
Journal:  Am Heart J       Date:  1977-10       Impact factor: 4.749

5.  Hemodynamic findings in Friedreich's ataxia.

Authors:  M Cote; A Davignon; G Elias; A Solignac; G Geoffroy; B Lemieux; A Barbeau
Journal:  Can J Neurol Sci       Date:  1976-11       Impact factor: 2.104

6.  Morphologic and functional characteristics of the heart in Friedreich's ataxia.

Authors:  D V Unverferth; W R Schmidt; P B Baker; C F Wooley
Journal:  Am J Med       Date:  1987-01       Impact factor: 4.965

7.  Progression of hypertrophic into a dilated left ventricle in Friedreich's ataxia.

Authors:  F Casazza; M Morpurgo
Journal:  G Ital Cardiol       Date:  1988-07

8.  Five-year follow-up of Friedreich's ataxia cardiomyopathy.

Authors:  R J Hawley; J S Gottdiener
Journal:  Arch Intern Med       Date:  1986-03

9.  Spectrum of cardiac involvement in Friedreich's ataxia: clinical, electrocardiographic and echocardiographic observations.

Authors:  E T Alboliras; C Shub; M R Gomez; W D Edwards; D J Hagler; G S Reeder; J B Seward; A J Tajik
Journal:  Am J Cardiol       Date:  1986-09-01       Impact factor: 2.778

10.  Cardiac involvement in Friedreich's ataxia: a clinical study of 75 patients.

Authors:  J S Child; J K Perloff; P M Bach; A D Wolfe; S Perlman; R A Kark
Journal:  J Am Coll Cardiol       Date:  1986-06       Impact factor: 24.094

View more
  21 in total

1.  Echocardiographic pitfalls in the diagnosis of hypertrophic cardiomyopathy.

Authors:  K Prasad; J Atherton; G C Smith; W J McKenna; M P Frenneaux; P Nihoyannopoulos
Journal:  Heart       Date:  1999-11       Impact factor: 5.994

2.  Cardiomyopathy of Friedreich's ataxia (FRDA).

Authors:  R M Payne; R E Peverill
Journal:  Ir J Med Sci       Date:  2012-02-29       Impact factor: 1.568

Review 3.  Hypertrophic cardiomyopathy in childhood.

Authors:  Steven D Colan
Journal:  Heart Fail Clin       Date:  2010-10       Impact factor: 3.179

Review 4.  Friedreich's ataxia: pathology, pathogenesis, and molecular genetics.

Authors:  Arnulf H Koeppen
Journal:  J Neurol Sci       Date:  2011-04-15       Impact factor: 3.181

Review 5.  Friedreich's Ataxia: a review from a cardiology perspective.

Authors:  T Bourke; D Keane
Journal:  Ir J Med Sci       Date:  2011-08-07       Impact factor: 1.568

6.  Friedreich's ataxia presenting after cardiac transplantation.

Authors:  H Leonard; R Forsyth
Journal:  Arch Dis Child       Date:  2001-02       Impact factor: 3.791

Review 7.  [Heart involvement in Friedreich's ataxia].

Authors:  F Weidemann; F Scholz; C Florescu; D Liu; K Hu; S Herrmann; G Ertl; S Störk
Journal:  Herz       Date:  2014-05-23       Impact factor: 1.443

8.  Inducible and reversible phenotypes in a novel mouse model of Friedreich's Ataxia.

Authors:  Vijayendran Chandran; Kun Gao; Vivek Swarup; Revital Versano; Hongmei Dong; Maria C Jordan; Daniel H Geschwind
Journal:  Elife       Date:  2017-12-19       Impact factor: 8.140

9.  Combined therapy with idebenone and deferiprone in patients with Friedreich's ataxia.

Authors:  Daniel Velasco-Sánchez; Asuncion Aracil; Raquel Montero; Ana Mas; Lorenzo Jiménez; Mar O'Callaghan; Maria Tondo; Antoni Capdevila; Josep Blanch; Rafael Artuch; Mercedes Pineda
Journal:  Cerebellum       Date:  2011-03       Impact factor: 3.847

10.  Idebenone and reduced cardiac hypertrophy in Friedreich's ataxia.

Authors:  A O Hausse; Y Aggoun; D Bonnet; D Sidi; A Munnich; A Rötig; P Rustin
Journal:  Heart       Date:  2002-04       Impact factor: 5.994

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.